RxSight (RXST) said Sunday it expects Q4 revenue of about $40.2 million, up roughly 41% from a year earlier.
Analysts polled by FactSet expect $40.4 million.
The company anticipates full-year 2024 revenue of $139.9 million. Analysts surveyed by FactSet expect $140 million.
For full-year 2025, RxSight expects revenue to come in between $185 million and $197 million. Analysts polled by FactSet expect $188 million.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。